Rangeley Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-92,500
Closed -$133K 80
2025
Q1
$133K Sell
92,500
-14,500
-14% -$20.9K 0.14% 63
2024
Q4
$235K Buy
+107,000
New +$235K 0.21% 55